These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Chambers HF Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879 [TBL] [Abstract][Full Text] [Related]
7. A general survey of antibiotic treatment of staphylococcal septicaemia and endocarditis. Watanakunakorn C Scand J Infect Dis Suppl; 1983; 41():151-7. PubMed ID: 6589752 [TBL] [Abstract][Full Text] [Related]
8. Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature. Baxi SM; Chan D; Jain V Infection; 2015 Dec; 43(6):751-4. PubMed ID: 25805524 [TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus bacteremia: A critical review of its treatment and association with infective endocarditis. Austin TW; Wallace JF Infection; 1973; 1(4):214-7. PubMed ID: 4494486 [No Abstract] [Full Text] [Related]
14. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia. McConeghy KW; Bleasdale SC; Rodvold KA Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343 [TBL] [Abstract][Full Text] [Related]
15. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Levine DP; Cushing RD; Jui J; Brown WJ Ann Intern Med; 1982 Sep; 97(3):330-8. PubMed ID: 7114630 [TBL] [Abstract][Full Text] [Related]
16. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model. Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849 [TBL] [Abstract][Full Text] [Related]
17. The association between Staphylococcus aureus bacteremia and bacteriuria. Lee BK; Crossley K; Gerding DN Am J Med; 1978 Aug; 65(2):303-6. PubMed ID: 686015 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial prophylaxis of experimental endocarditis caused by Staphylococcus epidermidis. Baddour LM; Hill MM; Felty-Duckworth AM Infection; 1989; 17(2):90-6. PubMed ID: 2714864 [TBL] [Abstract][Full Text] [Related]
19. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Chang FY; MacDonald BB; Peacock JE; Musher DM; Triplett P; Mylotte JM; O'Donnell A; Wagener MM; Yu VL Medicine (Baltimore); 2003 Sep; 82(5):322-32. PubMed ID: 14530781 [TBL] [Abstract][Full Text] [Related]